Medicare Enrolled
Dr. Eloy Roman, MD
Hematology & Oncology · Miami Lakes, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Roman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Roman
Dr. Eloy Roman is a hematology & oncology specialist in Miami Lakes, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Roman performed 157 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Roman received a total of $84,892 from 86 pharmaceutical and/or device companies across 1735 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 157 Medicare services
$84,892 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 91124 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗157
Medicare services
Bottom 11% in FL for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
146 | $105 | $160 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $129 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$84,892
Total received (2018-2024)
Avg $12,127/year across 7 years
Top 11% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,735
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$12,107
2023
$5,159
2022
$12,591
2021
$6,653
2020
$5,142
2019
$19,752
2018
$23,489
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$6,511
AstraZeneca Pharmaceuticals LP
$909
PFIZER INC.
$661
Celgene Corporation
$572
Janssen Biotech, Inc.
$430
Merck Sharp & Dohme LLC
$285
E.R. Squibb & Sons, L.L.C.
$268
Bayer Healthcare Pharmaceuticals Inc.
$236
GENZYME CORPORATION
$225
ABBVIE INC.
$182
Sumitomo Pharma America, Inc.
$173
Myriad Genetic Laboratories, Inc.
$154
Lilly USA, LLC
$131
Eisai Inc.
$126
BeiGene USA, Inc.
$126
Gilead Sciences, Inc.
$108
SpringWorks Therapeutics, Inc.
$101
Daiichi Sankyo Inc.
$94
Takeda Pharmaceuticals U.S.A., Inc.
$94
SOBI, INC
$92
Regeneron Healthcare Solutions, Inc.
$88
ARRAY BIOPHARMA INC
$81
Genentech USA, Inc.
$79
Apellis Pharmaceuticals, Inc.
$61
EMD Serono, Inc.
$54
Incyte Corporation
$33
JAZZ PHARMACEUTICALS INC.
$29
Exelixis Inc.
$28
Alexion Pharmaceuticals, Inc.
$27
Tempus AI, Inc
$24
Ipsen Biopharmaceuticals, Inc
$24
SERVIER PHARMACEUTICALS LLC
$24
Astellas Pharma US Inc
$21
PUMA BIOTECHNOLOGY, INC.
$21
Geron Corporation
$19
Stemline Therapeutics Inc.
$16
Top 3 companies account for 66.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$34,181
Alexion Pharmaceuticals, Inc.
$12,869
AstraZeneca Pharmaceuticals LP
$5,520
Apellis Pharmaceuticals, Inc.
$4,087
PFIZER INC.
$2,620
SWEDISH ORPHAN BIOVITRUM AB
$2,310
Janssen Biotech, Inc.
$2,195
E.R. Squibb & Sons, L.L.C.
$2,122
Incyte Corporation
$1,627
Celgene Corporation
$1,541
Merck Sharp & Dohme Corporation
$1,199
Merck Sharp & Dohme LLC
$891
Bayer HealthCare Pharmaceuticals Inc.
$873
Pharmacosmos Therapeutics Inc.
$721
GENZYME CORPORATION
$715
Eisai Inc.
$695
Astellas Pharma US Inc
$610
EMD Serono, Inc.
$557
GlaxoSmithKline, LLC.
$534
Bayer Healthcare Pharmaceuticals Inc.
$524
BeiGene USA, Inc.
$520
Genentech USA, Inc.
$484
Rigel Pharmaceuticals, Inc.
$421
Sumitomo Pharma America, Inc.
$393
Lilly USA, LLC
$370
Exelixis Inc.
$330
Amgen Inc.
$326
Pharmacyclics LLC, An AbbVie Company
$320
EISAI INC.
$314
ABBVIE INC.
$265
Myovant Sciences Inc.
$257
Kite Pharma, Inc.
$236
Seagen Inc.
$235
Regeneron Healthcare Solutions, Inc.
$229
AbbVie Inc.
$218
Takeda Pharmaceuticals U.S.A., Inc.
$206
MEDIVATION FIELD SOLUTIONS LLC
$203
Gilead Sciences, Inc.
$180
Myriad Genetic Laboratories, Inc.
$175
ARRAY BIOPHARMA INC
$169
Pharmacyclics LLC, an AbbVie Company
$158
SANOFI-AVENTIS U.S. LLC
$136
Daiichi Sankyo Inc.
$129
Stemline Therapeutics Inc.
$128
SOBI, INC
$120
ADC Therapeutics America, Inc.
$115
Taiho Oncology, Inc.
$110
TESARO, Inc.
$104
SpringWorks Therapeutics, Inc.
$101
Verastem, Inc.
$100
Epizyme, Inc.,
$98
JAZZ PHARMACEUTICALS INC.
$93
Dova Pharmaceuticals
$92
Ipsen Biopharmaceuticals, Inc
$86
Clovis Oncology, Inc.
$84
Teva Pharmaceuticals USA, Inc.
$81
Mirati Therapeutics, Inc.
$78
TAIHO ONCOLOGY, INC.
$71
Jazz Pharmaceuticals Inc.
$70
Sun Pharmaceutical Industries Inc.
$70
Array BioPharma Inc.
$56
Seattle Genetics, Inc.
$50
MorphoSys, US Inc.
$42
Janssen Pharmaceuticals, Inc
$40
AbbVie, Inc.
$33
Advanced Accelerator Applications
$32
Deciphera Pharmaceuticals Inc.
$32
Tempus AI, Inc
$24
SERVIER PHARMACEUTICALS LLC
$24
G1 Therapeutics, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$21
Acerta Pharma LLC
$20
Shire North American Group Inc
$20
Coherus Biosciences Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$19
Geron Corporation
$19
INSYS Therapeutics Inc
$18
Acceleron Pharma, Inc.
$18
AVEO Pharmaceuticals, Inc.
$17
Karyopharm Therapeutics Inc.
$16
AMAG Pharmaceuticals, Inc.
$15
Blue Earth Diagnostics Limited
$15
EUSA Pharma (US) LLC
$14
Lexicon Pharmaceuticals, Inc.
$13
CTI BioPharma Corp.
$13
Kyowa Kirin, Inc.
$12
Top 3 companies account for 61.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BAVENCIO · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · COSENTYX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · Fabhalta · GAZYVA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Imbruvica · Istodax · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · Monoferric · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Perjeta · Phesgo · Polivy · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · RYTELO · Reblozyl · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TORISEL · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYNDAQEL · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
197
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
PALMETTO GENERAL HOSPITAL
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Roman is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Roman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Roman performed 146 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Roman receive payments from pharmaceutical companies?
Yes. Dr. Roman received a total of $84,892 from 86 companies across 1,735 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roman's costs compare to other hematology & oncology specialists in Miami Lakes?
Dr. Roman's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Miami Lakes
Browse hematology & oncology specialists in Miami Lakes ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology